Our Mission is to keep our audience with an interrupted stream of financial information from serious sources, with the objective to provide the tools and the sufficient knowledge about investments in the financial markets.

Subscribe To

Translate

Search This Blog

Search Tool

Aug 28, 2018

Check out the companies making headlines before the bell:Tiffany – The luxury goods retailer reported quarterly earnings of $1.17 per share,
16 cents a share above estimates. Revenue and comparable-store sales
also beat forecasts and Tiffany raised its full-year earnings outlook.Best Buy – The electronics retailer came in 8 cents a share above estimates,
with adjusted quarterly profit of 91 cents per share. Revenue and
comparable-store sales also topped Street forecasts, however Best Buy's
current-quarter earnings guidance fell below analysts' estimates.DSW
– DSW earned an adjusted 63 cents per share for its second quarter,
well above the consensus estimate of 46 cents a share. Revenue also
exceeded forecasts, and a comparable-store sales increase of 9.7 percent
easily beat the consensus 2.5 percent estimate.Apple
– Apple's next iPhone series – expected to be introduced next month –
are likely to have more favorable momentum than previous iPhones,
according to industry sources quoted by DigiTimes. That will likely
result in record quarterly revenue for Apple suppliers Taiwan Semiconductor and Foxconn.Starbucks
– Starbucks and Switzerland's Nestle have finalized a $7.15 billion
licensing deal. Under the pact, Nestle will get the rights to sell
Starbucks products in places other than the company's U.S. coffee shops.Twitter
– Twitter has suspended a total of 770 accounts for engaging in
coordinated manipulation and for other policy violations. It said many
of the accounts involved in the alleged manipulation appear to have
originated from Iran.Ionis Pharmaceuticals – Ionis and Akcea Therapeutics
suffered a setback when the Food and Drug Administration declined to
approve a drug designed to treat a genetic disease that causes fat to
accumulate in the blood. The decision came as a surprise, since an FDA
panel had voted in favor of approving the drug in May.Aspen Insurance – Aspen will be bought by funds affiliated with Apollo Global Management
for $2.6 billion, or $42.75 per share. That represents a 6.6 percent
premium over Monday's closing price for the specialty insurer company's
stock.Gap
– The apparel retailer's stock was upgraded to "neutral" from "sell" at
Citi, based on current price levels following recent underperformance.Xilinx
– Xilinx was upgraded to "outperform" from "neutral" at RW Baird, with
the firm pointing to some recent contract wins for the specialty chip
maker.Campbell Soup
– The food company will announce this week that it does not plan to
sell the entire company, according to sources quoted by the New York
Post. Those sources say such a move could provoke a proxy fight by
investor Daniel Loeb's Third Point against Campbell's board.Heico
– Heico earned 49 cents per share for its third quarter, 4 cents a
share above estimates. The defense and aerospace company's revenue also
topped Wall Street forecasts. Heico said it saw double-digit organic
revenue growth at its Flight Support and Electronic Technologies
businesses

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

FRAUDE DE LOS BANCOS-PERÚ

If you are are investigating a fraud case and need to contact MasterCard to assist with the investigation. Who can we speak with?

A: Please send an email to our Law Enforcement Support Center at Law_Enforcement_Support@mastercard.com, or call 1-866-308-7272 (U.S. & Canada) or 1-636-722-4046 (International). We will respond to your inquiry within 24-48 hours.